{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:56:05Z","timestamp":1785700565011,"version":"3.56.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136622"],"award-info":[{"award-number":["R01HL136622"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1053\/j.seminhematol.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:06:08Z","timestamp":1778367968000},"page":"37-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolving insights into mitochondrial presence in RBC in sickle cell disease: Red blood cell and reticulocyte pathophysiology, therapeutic strategies, and future directions"],"prefix":"10.1053","volume":"63","author":[{"given":"Yaw","family":"Ansong-Ansongton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Zapet Bamac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2026.05.003_bib0001","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0002","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0003","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2022.2163357","article-title":"A systematic review comparing allogeneic hematopoietic stem cell transplant to gene therapy in sickle cell disease","volume":"28","author":"Rotin","year":"2023","journal-title":"Hematology"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2022.102660","article-title":"Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model","volume":"95","author":"Quezado","year":"2022","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0006","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exphem.2017.02.003","article-title":"Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease","volume":"50","author":"Jagadeeswaran","year":"2017","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2025.105269","article-title":"Mitochondrial retention and autophagy dysregulation drive oxidative stress in sickle cell disease erythrocytes","volume":"152","author":"Ramasamy","year":"2025","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0008","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjh.18287","article-title":"Retention of functional mitochondria in mature red blood cells from patients with sickle cell disease","volume":"198","author":"Moriconi","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0009","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/bjh.17416","article-title":"Deficient mitophagy pathways in sickle cell disease","volume":"193","author":"Martino","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0010","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1182\/blood.2020009063","article-title":"Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease","volume":"137","author":"Tumburu","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0011","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ncb3527","article-title":"Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation","volume":"19","author":"Liu","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0012","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bjh.19600","article-title":"Mitochondrial regulation of erythropoiesis in homeostasis and disease","volume":"205","author":"Menon","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96585-0","article-title":"Decreased PGC1\u03b2 expression results in disrupted human erythroid differentiation, impaired hemoglobinization and cell cycle exit","volume":"11","author":"Sen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0014","article-title":"Role of calcium\/calcineurin signalling in regulating intracellular reactive oxygen species homeostasis in saccharomyces cerevisiae","volume":"12","author":"Li","year":"2021","journal-title":"Genes"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1236651","article-title":"Mitochondrial quality control in lung diseases: current research and future directions","volume":"14","author":"Liu","year":"2023","journal-title":"Front Physiol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0016","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11033-024-09232-y","article-title":"PGC1-\u03b1 in diabetic kidney disease: unraveling renoprotection and molecular mechanisms","volume":"51","author":"Ye","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coemr.2019.02.002","article-title":"Mitochondrial regulator PGC-1a-modulating the modulator","volume":"5","author":"Miller","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005526","article-title":"A systems approach identifies essential FOXO3 functions at key steps of terminal erythropoiesis","volume":"11","author":"Liang","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0019","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature07006","article-title":"Essential role for Nix in autophagic maturation of erythroid cells","volume":"454","author":"Sandoval","year":"2008","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mvr.2009.01.010","article-title":"Effects of erythrocyte deformability and aggregation on the cell free layer and apparent viscosity of microscopic blood flows","volume":"77","author":"Zhang","year":"2009","journal-title":"Microvasc Res"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0021","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2008-02-137398","article-title":"Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation","volume":"112","author":"Kundu","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.exphem.2022.11.007","article-title":"Heme-dependent induction of mitophagy program during differentiation of murine erythroid cells","volume":"118","author":"Ikeda","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0023","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2015-02-626259","article-title":"The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice","volume":"126","author":"Cui","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0024","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3324\/haematol.2023.282684","article-title":"Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress","volume":"108","author":"Esperti","year":"2023","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0025","article-title":"MCOLN1 is a ROS sensor in lysosomes that regulates autophagy","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0026","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1080\/15548627.2016.1239679","article-title":"Regulation of lysosomal dynamics and autophagy by CTSB\/cathepsin B","volume":"12","author":"Man","year":"2016","journal-title":"Autophagy"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0027","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1080\/15548627.2021.1984656","article-title":"Full-coverage regulations of autophagy by ROS: from induction to maturation","volume":"18","author":"Zhou","year":"2022","journal-title":"Autophagy"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0028","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.freeradbiomed.2017.05.005","article-title":"Differential redox sensitivity of cathepsin B and L holds the key to autophagy-apoptosis interplay after thioredoxin reductase inhibition in nutritionally stressed SH-SY5Y cells","volume":"108","author":"Nagakannan","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25074087","article-title":"The intricate balance between life and death: ROS, cathepsins, and their interplay in cell death and autophagy","volume":"25","author":"Voronina","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240632","article-title":"Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: a pilot study","volume":"15","author":"Barbanera","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0031","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2020-138518","article-title":"Mitochondrial DNA variation in individuals with sickle cell disease","volume":"136","author":"Ahmad","year":"2020","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0032","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1038\/ncomms7494","article-title":"MtDNA mutagenesis impairs elimination of mitochondria during erythroid maturation leading to enhanced erythrocyte destruction","volume":"6","author":"Ahlqvist","year":"2015","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1113\/JP287673","article-title":"Metabolic stimulation improves bioenergetics and haematologic indices of circulating erythrocytes from sickle cell mice","author":"Almeida","year":"2025","journal-title":"J Physiol (Lond)"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2024.104153","article-title":"Metabolic regulation of erythrocyte development and disorders","volume":"131","author":"Lyu","year":"2024","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0035","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s12288-023-01640-7","article-title":"Depolarized mitochondrial membrane potential and elevated calcium in platelets of sickle cell disease","volume":"39","author":"Maharana","year":"2023","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0036","doi-asserted-by":"crossref","DOI":"10.31083\/RCM26613","article-title":"Key mechanisms of oxidative stress-induced ferroptosis in heart failure with preserved ejection fraction and potential therapeutic approaches","volume":"26","author":"Lin","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0037","article-title":"Higher calcium levels exacerbate sickling of RBC-retaining mitochondria in pediatric SCD patients","author":"Nyansa Ansong-Ansongton","year":"2026","journal-title":"Blood Red Cell Iron"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.brci.2025.100015","article-title":"New sickle cell disease therapies modulate red blood cell deformability via Ca2+, ATP, and 2,3-DPG in normoxia and hypoxia","volume":"1","author":"Sekyonda","year":"2025","journal-title":"Blood Red Cells & Iron"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0039","article-title":"Endothelial superoxide dismutase 2 is decreased in sickle cell disease and regulates fibronectin processing","volume":"3","author":"Dosunmu-Ogunbi","year":"2022","journal-title":"Function (Oxf)"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.2021013350","article-title":"SOD2 V16A amplifies vascular dysfunction in sickle cell patients by curtailing mitochondria complex IV activity","volume":"139","author":"Dosunmu-Ogunbi","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083675","article-title":"Crosstalk between sickle cell disease and ferroptosis","volume":"26","author":"Russo","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0042","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10238-024-01555-1","article-title":"The involvement of mitochondria in erythrocyte pathology and diseases: from mechanisms to therapeutic strategies","volume":"25","author":"Lin","year":"2025","journal-title":"Clin Exp Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0043","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0003-9861(91)90224-7","article-title":"Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide","volume":"288","author":"Radi","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0044","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/jsre.1999.5801","article-title":"Adaptive responses of the endothelium to stress","volume":"89","author":"Pohlman","year":"2000","journal-title":"J Surg Res"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0045","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/bloodadvances.2019000527","article-title":"Decoding the role of SOD2 in sickle cell disease","volume":"3","author":"Dosunmu-Ogunbi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0046","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0531-5565(00)00118-2","article-title":"Role of redox-regulated transcription factors in inflammation, aging and age-related diseases","volume":"35","author":"Lavrovsky","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0047","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1172\/JCI116778","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells","volume":"92","author":"Marui","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0048","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/blood.V85.1.268.bloodjournal851268","article-title":"Sickle reticulocytes adhere to VCAM-1","volume":"85","author":"Gee","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0049","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood.V92.10.3924","article-title":"Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes","volume":"92","author":"Sultana","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0051","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bjh.14693","article-title":"Association between oxidative stress and vascular reactivity in children with sickle cell anaemia and sickle haemoglobin C disease","volume":"178","author":"M\u00f6ckesch","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0052","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0053","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0054","article-title":"Hydroxyurea (hydroxycarbamide) for sickle cell disease","volume":"9","author":"Rankine-Mullings","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102673","article-title":"Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects","volume":"24","author":"Cheng","year":"2021","journal-title":"IScience"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0056","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41419-024-07296-z","article-title":"Hydroxyurea blunts mitochondrial energy metabolism and osteoblast and osteoclast differentiation exacerbating trabecular bone loss in sickle cell mice","volume":"15","author":"Tripathi","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0057","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0058","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ajh.27692","article-title":"Arginine therapy for pain in Sickle cell disease: a phase-2 randomized, placebo-controlled trial","volume":"100","author":"Morris","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0059","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.2019003672","article-title":"Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain","volume":"136","author":"Morris","year":"2020","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI106324","article-title":"The interaction of 2,3-diphosphoglycerate with various human hemoglobins","volume":"49","author":"Bunn","year":"1970","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0061","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1182\/blood.V76.5.1028.1028","article-title":"2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S","volume":"76","author":"Poillon","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0062","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1182\/blood.V85.11.3289.bloodjournal85113289","article-title":"Antisickling effects of 2,3-diphosphoglycerate depletion","volume":"85","author":"Poillon","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0063","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2141.2008.07473.x","article-title":"Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes","volume":"144","author":"Sabina","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0064","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.754638","article-title":"Generation and export of red blood cell ATP in health and disease","volume":"12","author":"McMahon","year":"2021","journal-title":"Front Physiol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0065","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa2116634","article-title":"Mitapivat versus Placebo for pyruvate kinase deficiency","volume":"386","author":"Al-Samkari","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0066","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.2022015403","article-title":"A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease","volume":"140","author":"Xu","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0067","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/jpet.121.000743","article-title":"Etavopivat, a pyruvate kinase activator in red blood cells, for the treatment of sickle cell disease","volume":"380","author":"Schroeder","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0068","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/bloodadvances.2020003604","article-title":"FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and hb levels in SCA mice","volume":"5","author":"Shrestha","year":"2021","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26554","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: a phase 2, open-label study","volume":"97","author":"van Dijk","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0070","article-title":"Antioxidant supplementation for sickle cell disease","volume":"5","author":"Bolarinwa","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0071","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.14809","article-title":"Effect of N-acetylcysteine on pain in daily life in patients with sickle cell disease: a randomised clinical trial","volume":"182","author":"Sins","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0072","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00277-011-1404-z","article-title":"N-acetylcysteine reduces oxidative stress in sickle cell patients","volume":"91","author":"Nur","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0073","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/blood.2024028006","article-title":"Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model","volume":"146","author":"Wang","year":"2025","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0074","doi-asserted-by":"crossref","first-page":"R840","DOI":"10.1152\/ajpregu.00440.2017","article-title":"Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data","volume":"315","author":"Rivers","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in friedreich ataxia (moxie study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0076","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1113\/jphysiol.2013.268680","article-title":"Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice","volume":"592","author":"Gioscia-Ryan","year":"2014","journal-title":"J Physiol (Lond)"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1506460","article-title":"Overview of MitoQ on prevention and management of cardiometabolic diseases: a scoping review","volume":"12","author":"Pang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2022.100037","article-title":"Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases","volume":"5","author":"Sulaimon","year":"2022","journal-title":"Advances in Redox Research"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109172","article-title":"Disruption of mitochondrial energy metabolism is a putative pathogenesis of Diamond-Blackfan anemia","volume":"27","author":"Xiao","year":"2024","journal-title":"IScience"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107542","article-title":"Activation of nemo-like kinase in diamond blackfan anemia suppresses early erythropoiesis by preventing mitochondrial biogenesis","volume":"300","author":"Wilkes","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0081","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","article-title":"Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE","volume":"184","author":"Caielli","year":"2021","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0082","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood-2025-2896","article-title":"Pyruvate kinase deficiency is associated with mitochondrial retention, decreased antioxidant and HIFs activity correlating with hemolysis","volume":"146","author":"Song","year":"2025","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0083","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.195682","article-title":"Pyruvate kinase deficiency modifies sickle hemoglobin carrier and sickle cell disease phenotypes in mice","author":"Wang","year":"2026","journal-title":"JCI Insight"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0084","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.916197","article-title":"Plasma levels of acyl-carnitines and carboxylic acids correlate with cardiovascular and kidney function in subjects with sickle cell trait","volume":"13","author":"Nemkov","year":"2022","journal-title":"Front Physiol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041095","article-title":"Are mitochondria a potential target for treating \u03b2-thalassemia?","volume":"14","author":"Di Pierro","year":"2025","journal-title":"J Clin Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0086","doi-asserted-by":"crossref","DOI":"10.1097\/MPH.0000000000002901","article-title":"Hereditary spherocytosis with mitochondrial retention, increased oxidative stress, and alterations to bioactive membrane lipids","volume":"46","author":"Principe","year":"2024","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0087","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/CH-238122","article-title":"Blood rheology and vascular function in sickle cell trait and sickle cell disease: from pathophysiological mechanisms to clinical usefulness","volume":"86","author":"Connes","year":"2024","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0088","article-title":"Mitochondrial dysfunction in sickle cell trait carriers with exertional collapse","volume":"2025","author":"Cofer","year":"2025","journal-title":"Case Rep Genet"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0089","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12069-0","article-title":"Retention of mitochondria in mature human red blood cells as the result of autophagy impairment in rett syndrome","volume":"7","author":"Sbardella","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0090","article-title":"MeCP2 dysregulation inhibits mitophagy and impairs neural development in cortical organoids","author":"Zhou","year":"2025","journal-title":"J Advanc Res"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0091","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exphem.2023.02.005","article-title":"Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia","volume":"122","author":"Gallivan","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.70130","article-title":"Dual assessment of the RBC fraction abnormally retaining mitochondria and of the RBC mitochondrial load provides a new clinical parameter for sickle cell disease patients","volume":"6","author":"Soupene","year":"2025","journal-title":"EJHaem"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0093","article-title":"Deep learning-driven automated mitochondrial segmentation for analysis of complex transmission electron microscopy images","volume":"15","author":"Jang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0094","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3324\/haematol.2018.207357","article-title":"Emerging disease-modifying therapies for sickle cell disease","volume":"104","author":"Carden","year":"2019","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0095","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/ajh.23777","article-title":"Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease","volume":"89","author":"Meier","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0096","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070794","article-title":"Increased reticulocytosis during infancy is associated with increased hospitalizations in sickle cell anemia patients during the first three years of life","volume":"8","author":"Meier","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0097","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1126\/science.aaz2740","article-title":"Cell-specific transcriptional control of mitochondrial metabolism by TIF1\u03b3 drives erythropoiesis","volume":"372","author":"Rossmann","year":"2021","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0098","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ymgme.2009.11.005","article-title":"Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade","volume":"99","author":"Kerr","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0099","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0101","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/brain\/awx168","article-title":"Monitoring clinical progression with mitochondrial disease biomarkers","volume":"140","author":"Steele","year":"2017","journal-title":"Brain"},{"key":"10.1053\/j.seminhematol.2026.05.003_bib0102","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005255","article-title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","volume":"90","author":"Karaa","year":"2018","journal-title":"Neurology"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:40:32Z","timestamp":1785699632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0037196326000417"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.05.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving insights into mitochondrial presence in RBC in sickle cell disease: Red blood cell and reticulocyte pathophysiology, therapeutic strategies, and future directions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}